Boothbay Fund Management, LLC Poseida Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.08 - $8.73 $4,158 - $11,785	-1,350 Reduced 7.88%	15,792 $48,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $57,082 - $109,365	17,142 New	17,142 $90,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $94,325 - $142,485	-13,304 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.96 - $10.07 $105,899 - $133,971	13,304 New	13,304 $133,000
Q1 2021 May 17, 2021	SELL	$8.51 - $11.91 $230,680 - $322,844	-27,107 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$8.29 - $11.7 $17,939 - $25,318	2,164 Added 8.68%	27,107 $297,000
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $201,788 - $405,323	24,943 New	24,943 $221,000

105

38.9M

451K

146K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.